Silexion Therapeutics announces 1-for-10 reverse share split to maintain Nasdaq listing

Silexion Therapeutics Corp

Reverse share split at 1:10 ratio; effective after market close May 28, 2026; split-adjusted trading begins May 29, 2026.
Ticker remains SLXN; new CUSIP assigned; par value increases from $0.0135 to $0.135 per share.
No fractional shares issued; DTC participants' fractional shares rounded up to nearest whole share.
Split intended to maintain Nasdaq minimum bid price compliance (Rule 5550(a)(2)) and support equity financings.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001178913-26-002900
form_type: 8-K
ticker: SLXN
cik: 0002022416
company_name: Silexion Therapeutics Corp
filed_at: 2026-05-26T12:48:49+00:00
discovered_at: 2026-05-26T12:50:00.888047+00:00
generated_at: 2026-05-26T12:50:27.315562+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001178913-26-002900
json_url: https://secwatch.observer/filing/0001178913-26-002900.json
markdown_url: https://secwatch.observer/filing/0001178913-26-002900.md
text_url: https://secwatch.observer/filing/0001178913-26-002900.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2022416/000117891326002900/0001178913-26-002900-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2022416/000117891326002900/zk2635400.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001178913-26-002900

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.